CRESCENT BIOPHARMA, INC. Increase (Decrease) in Deposits Outstanding
CRESCENT BIOPHARMA, INC. (CBIO) reported Increase (Decrease) in Deposits Outstanding of $52.32 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositsOutstanding · last filed 2019-03-06
- CRESCENT BIOPHARMA, INC. increase (decrease) in deposits outstanding for the quarter ending 2016-12-31 was $0.00.
- CRESCENT BIOPHARMA, INC. increase (decrease) in deposits outstanding for the quarter ending 2016-09-30 was $0.00.
- CRESCENT BIOPHARMA, INC. increase (decrease) in deposits outstanding for fiscal 2016 was $52.32K.
| Period end | Increase (Decrease) in Deposits Outstanding 3 month | Increase (Decrease) in Deposits Outstanding 6 month | Increase (Decrease) in Deposits Outstanding 6 month as first filed | Increase (Decrease) in Deposits Outstanding 9 month | Increase (Decrease) in Deposits Outstanding 9 month as first filed | Increase (Decrease) in Deposits Outstanding 12 month |
|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $52.32K 10-K · filed 2019-03-06 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $52.32K 10-Q · filed 2017-11-08 | -$52.32K 10-Q · filed 2016-11-04 | |||
| 2016-06-30 | $52.32K 10-Q · filed 2017-08-03 | -$52.32K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |